Given the buoyant demand environment, the companies that have invested in the expansion of their business operations are likely to perform ...

The transaction will be financed through borrowings and will achieve financial closure in the next few days, the drug firm said. In a separ...

The nine brands have sales of Rs 87.30 crores for FY22, which represents valuation of 3.9x of the sales of these brands in FY22. The acquir...

IndusInd Bank will report its earnings for the December quarter on Wednesday. The bank is expected to report strong growth in income on the...

Softening raw material costs, NELM price hike and improved valuations play positive roles.

Through acquisition of Strides domestic formulations portfolio in 2017, Eris Lifesciences got a toehold in the neurology and psychiatry seg...

The launch of long acting insulin glargine will help Eris to fill the gap in its insulin portfolio. Eris derives more than half of its reve...

The drug maker said the acquisition will be completed by way of a share purchase agreement as a result of which Oaknet will become a wholly...

South Africa’s second largest drug maker Adcock Ingram is in advanced talks to sell part of its India business to Oaknet Lifesciences.